{
  "episodeNumber": 72,
  "title": "UKW072: Corona Weekly: Geisterfahrerfreie Zone",
  "generatedAt": "2026-01-05T15:18:03.018Z",
  "dataSource": "extended-topics",
  "radarChart": {
    "values": {
      "Health": 0.984493041749503,
      "Politics": 0,
      "Military": 0,
      "Technology": 0,
      "Economics": 0,
      "Media": 0,
      "Miscellaneous": 0.015506958250497018,
      "Society": 0,
      "Travel": 0,
      "Social": 0,
      "Economy": 0,
      "Geopolitics": 0
    },
    "durations": {
      "Health": 7428,
      "Politics": 0,
      "Military": 0,
      "Technology": 0,
      "Economics": 0,
      "Media": 0,
      "Miscellaneous": 117,
      "Society": 0,
      "Travel": 0,
      "Social": 0,
      "Economy": 0,
      "Geopolitics": 0
    },
    "topicCounts": {
      "Health": 17,
      "Politics": 0,
      "Military": 0,
      "Technology": 0,
      "Economics": 0,
      "Media": 0,
      "Miscellaneous": 1,
      "Society": 0,
      "Travel": 0,
      "Social": 0,
      "Economy": 0,
      "Geopolitics": 0
    },
    "totalDurationSec": 7545,
    "totalTopics": 18
  },
  "timeline": [
    {
      "subject": "Health",
      "startSec": 273,
      "endSec": 676,
      "durationSec": 403,
      "topic": "Infektionszahlen Deutschland",
      "fineSubject": "Infection Rates",
      "topicIndex": 0
    },
    {
      "subject": "Health",
      "startSec": 676,
      "endSec": 935,
      "durationSec": 259,
      "topic": "Inzidenzen nach Altersgruppen",
      "fineSubject": "Demographics",
      "topicIndex": 1
    },
    {
      "subject": "Health",
      "startSec": 936,
      "endSec": 1065,
      "durationSec": 129,
      "topic": "Situation der Bundesländer",
      "fineSubject": "Regional Analysis",
      "topicIndex": 2
    },
    {
      "subject": "Health",
      "startSec": 1065,
      "endSec": 1254,
      "durationSec": 189,
      "topic": "Todesfälle",
      "fineSubject": "Mortality",
      "topicIndex": 3
    },
    {
      "subject": "Health",
      "startSec": 1255,
      "endSec": 1577,
      "durationSec": 322,
      "topic": "Situation in Berlin",
      "fineSubject": "Regional Analysis",
      "topicIndex": 4
    },
    {
      "subject": "Health",
      "startSec": 1578,
      "endSec": 1941,
      "durationSec": 363,
      "topic": "Tests und Positivquote",
      "fineSubject": "Testing",
      "topicIndex": 5
    },
    {
      "subject": "Health",
      "startSec": 1941,
      "endSec": 2214,
      "durationSec": 273,
      "topic": "Internationaler Vergleich",
      "fineSubject": "International Comparison",
      "topicIndex": 6
    },
    {
      "subject": "Health",
      "startSec": 2215,
      "endSec": 2611,
      "durationSec": 396,
      "topic": "Änderung der Messmethoden durch das RKI?",
      "fineSubject": "Methodology",
      "topicIndex": 7
    },
    {
      "subject": "Health",
      "startSec": 2611,
      "endSec": 2982,
      "durationSec": 371,
      "topic": "Der Anfang vom Ende?",
      "fineSubject": "Outlook",
      "topicIndex": 8
    },
    {
      "subject": "Health",
      "startSec": 2982,
      "endSec": 3578,
      "durationSec": 596,
      "topic": "Die Dunkelziffer von Tirschenreuth",
      "fineSubject": "Statistics",
      "topicIndex": 9
    },
    {
      "subject": "Health",
      "startSec": 3579,
      "endSec": 4052,
      "durationSec": 473,
      "topic": "Fortschritt der Impfkampagne",
      "fineSubject": "Vaccination",
      "topicIndex": 10
    },
    {
      "subject": "Health",
      "startSec": 4052,
      "endSec": 4408,
      "durationSec": 356,
      "topic": "Neue Freigaben für AstraZeneca",
      "fineSubject": "Vaccination Policy",
      "topicIndex": 11
    },
    {
      "subject": "Health",
      "startSec": 4408,
      "endSec": 5741,
      "durationSec": 1333,
      "topic": "Nachweise der Impfungen",
      "fineSubject": "Vaccination Documentation",
      "topicIndex": 12
    },
    {
      "subject": "Health",
      "startSec": 5742,
      "endSec": 5899,
      "durationSec": 157,
      "topic": "RKI-Studie zur Wirkung der Impfungen",
      "fineSubject": "Vaccination Efficacy",
      "topicIndex": 13
    },
    {
      "subject": "Health",
      "startSec": 5899,
      "endSec": 6049,
      "durationSec": 150,
      "topic": "Impfstoffe vs. Varianten",
      "fineSubject": "Vaccination Challenges",
      "topicIndex": 14
    },
    {
      "subject": "Health",
      "startSec": 6049,
      "endSec": 7294,
      "durationSec": 1245,
      "topic": "Impfstoffpatente",
      "fineSubject": "Intellectual Property",
      "topicIndex": 15
    },
    {
      "subject": "Health",
      "startSec": 7294,
      "endSec": 7707,
      "durationSec": 413,
      "topic": "Fazit",
      "fineSubject": "Conclusion",
      "topicIndex": 16
    },
    {
      "subject": "Miscellaneous",
      "startSec": 7840,
      "endSec": 7957,
      "durationSec": 117,
      "topic": "Bonus Track",
      "fineSubject": "Additional Content",
      "topicIndex": 17
    }
  ]
}
